Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Sheward

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2012
Degenerate Primer IDs and the birthday problemDaniel J Sheward, Ben Murrell, Carolyn Williamson
The Journal of Infectious Diseases|March 11, 2015
HIV-1 Superinfection Resembles Primary InfectionDaniel J Sheward, Roman Ntale, Nigel J Garrett, et al.
Scientific Reports|February 5, 2021
DNA-launched RNA replicon vaccines induce potent anti-SARS-CoV-2 immune responses in miceInga Szurgot, Leo Hanke, Daniel J Sheward, et al.
Biomolecules|December 16, 2020
Picomolar SARS-CoV-2 Neutralization Using Multi-Arm PEG Nanobody ConstructsAinhoa Moliner-Morro, Daniel J Sheward, Vivien Karl, et al.
Journal of Virology|June 27, 2022
HIV Coinfection Provides Insights for the Design of Vaccine Cocktails to Elicit Broadly Neutralizing AntibodiesDaniel J Sheward, Tandile Hermanus, Ben Murrell, et al.
Frontiers in Virology (Lausanne, Switzerland)|April 12, 2023
Frequent use of IGHV3-30-3 in SARS-CoV-2 neutralizing antibody responsesPradeepa Pushparaj, Andrea Nicoletto, Xaquin Castro Dopico, et al.
Frontiers in Bioengineering and Biotechnology|December 29, 2022
Silver nanoparticles with excellent biocompatibility block pseudotyped SARS-CoV-2 in the presence of lung surfactantGovind Gupta, Bejan Hamawandi, Daniel J Sheward, et al.
The Lancet. Infectious Diseases|September 30, 2023
Sensitivity of the SARS-CoV-2 BA.2.86 variant to prevailing neutralising antibody responsesDaniel J Sheward, Yiqiu Yang, Michelle Westerberg, et al.
Ebiomedicine|January 10, 2021
Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in miceKatharina Wørzner, Daniel J Sheward, Signe Tandrup Schmidt, et al.
The Lancet. Infectious Diseases|January 8, 2024
Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in SwedenUlrika Marking, Oscar Bladh, Katherina Aguilera, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|April 21, 2012
Degenerate Primer IDs and the birthday problemDaniel J Sheward, Ben Murrell, Carolyn Williamson
The Journal of Infectious Diseases|March 11, 2015
HIV-1 Superinfection Resembles Primary InfectionDaniel J Sheward, Roman Ntale, Nigel J Garrett, et al.
Scientific Reports|February 5, 2021
DNA-launched RNA replicon vaccines induce potent anti-SARS-CoV-2 immune responses in miceInga Szurgot, Leo Hanke, Daniel J Sheward, et al.
Biomolecules|December 16, 2020
Picomolar SARS-CoV-2 Neutralization Using Multi-Arm PEG Nanobody ConstructsAinhoa Moliner-Morro, Daniel J Sheward, Vivien Karl, et al.
Journal of Virology|June 27, 2022
HIV Coinfection Provides Insights for the Design of Vaccine Cocktails to Elicit Broadly Neutralizing AntibodiesDaniel J Sheward, Tandile Hermanus, Ben Murrell, et al.
Frontiers in Virology (Lausanne, Switzerland)|April 12, 2023
Frequent use of IGHV3-30-3 in SARS-CoV-2 neutralizing antibody responsesPradeepa Pushparaj, Andrea Nicoletto, Xaquin Castro Dopico, et al.
Frontiers in Bioengineering and Biotechnology|December 29, 2022
Silver nanoparticles with excellent biocompatibility block pseudotyped SARS-CoV-2 in the presence of lung surfactantGovind Gupta, Bejan Hamawandi, Daniel J Sheward, et al.
The Lancet. Infectious Diseases|September 30, 2023
Sensitivity of the SARS-CoV-2 BA.2.86 variant to prevailing neutralising antibody responsesDaniel J Sheward, Yiqiu Yang, Michelle Westerberg, et al.
Ebiomedicine|January 10, 2021
Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in miceKatharina Wørzner, Daniel J Sheward, Signe Tandrup Schmidt, et al.
The Lancet. Infectious Diseases|January 8, 2024
Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in SwedenUlrika Marking, Oscar Bladh, Katherina Aguilera, et al.
Pageof 5